Your browser doesn't support javascript.
loading
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.
Caronna, E; José Gallardo, V; Alpuente, A; Torres-Ferrus, M; Sánchez-Mateo, N M; Viguera-Romero, J; López-Veloso, A C; López-Bravo, A; Gago-Veiga, A B; Irimia Sieira, P; Porta-Etessam, J; Santos-Lasaosa, S; Pozo-Rosich, P.
Afiliação
  • Caronna E; Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona
  • José Gallardo V; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Alpuente A; Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona
  • Torres-Ferrus M; Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona
  • Sánchez-Mateo NM; Headache Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Viguera-Romero J; Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • López-Veloso AC; Neurology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain.
  • López-Bravo A; Neurology Department, Hospital Reina Sofia, Tudela, Spain.
  • Gago-Veiga AB; Headache Unit, Neurology Department, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.
  • Irimia Sieira P; Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain.
  • Porta-Etessam J; Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain.
  • Santos-Lasaosa S; Headache Unit, Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Pozo-Rosich P; Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona
Neurologia (Engl Ed) ; 2021 Mar 19.
Article em En, Es | MEDLINE | ID: mdl-33832802
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En / Es Revista: Neurologia (Engl Ed) Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En / Es Revista: Neurologia (Engl Ed) Ano de publicação: 2021 Tipo de documento: Article